< Back to companies
Algen

Algen

AI-powered causal biology for drug discovery

San Francisco, CA, US

Algen is a platform company focused on drug target discovery, utilizing CRISPR technology and machine learning to decode causal biology and identify disease-driving mechanisms. It also focuses on RNA message modulation at single-cell resolution.

Share
Shareable draft
Hero image for Algen
Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.
Get Involved in Algen

Problem Statement

The difficulty in decoding causal biology and identifying disease-driving mechanisms for effective drug target discovery.

Core Technology

CRISPR technology, machine learning, RNA message modulation at single-cell resolution, AlgenBrain platform for AI-powered drug discovery

Key Differentiators

Utilizes CRISPR technology and machine learning to decode causal biology; Focuses on RNA message modulation at single-cell resolution; Spun out from UC Berkeley Nobel laureate Jennifer Doudna's lab; AlgenBrain platform for AI-powered drug discovery

Clinical Focus

Immuno-oncology; Autoimmune diseases

Company Info

Business Model
Other
Founded
2018
Total Funding
Only accessible to MedStartr community members. Join now
Website
www.algen.co

Categories

Drug Discovery/Development

Disease Areas

Technologies

Machine LearningRNA Message ModulationGene Editing & CRISPRAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

Lead oncology candidate preparing for clinical trials; $555M AstraZeneca partnership validates scientific approach

Only accessible to MedStartr community members. Join now

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Sign in to join the conversation.

Sign in to comment
Be the first to comment.

What do you think of Algen?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in Algen
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free